(Q52579549)

English

Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.

scientific article published in June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. (English)

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Chang-Shi Chen

1

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Yu-Chieh Wang

2

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Hsiao-Ching Yang

3

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Po-Hsien Huang

4

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Samuel K Kulp

5

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Chih-Cheng Yang

6

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Yen-Shen Lu

7

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Shigemi Matsuyama

8

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Ching-Yu Chen

9

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Ching-Shih Chen

10

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

language of work or name

0 references

publication date

1 June 2007

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Cancer Research

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

67

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

5318-5327

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

11

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1158/1078-0432.CCR-06-0429

Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1038/NCB955

Ku70 suppresses the apoptotic translocation of Bax to mitochondria.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1038/NCB950

Identifiers

10.1158/0008-5472.CAN-06-3996

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/17545612

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52579549&oldid=2079969525"